11
CURRENT LAW AND PRACTICE ISSUES IN THE STATE AND NATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director, MPA

C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

Embed Size (px)

Citation preview

Page 1: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

CURRENT LAW AND PRACTICE ISSUES IN THE STATE AND NATIONTony King, PharmD

Corey Heffernan, PharmD

Mark Meredith, PharmD

Stuart Doggett, Executive Director, MPA

Page 2: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

TOPICS

National Issues US Pharmacy Caucus Compounding FDA Hot Topics

Board of Pharmacy EO Position Update Compounding (again) Rules Updates

State Legislative Issues Legislative Tracking List MPA’s 2 Bills Pharmacy Day at the Capitol

Page 3: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

NATIONAL ISSUES

US Pharmacy Caucus Sen. Tester No Contact with MPA

Compounding Tragedy FDA

Page 4: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

TRAGEDIES DRIVE LEGISLATION

Page 5: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

BOARD OF PHARMACY

Executive Officer Position Update Biennial rule review MAR notice Compounding Rules

Sterile and Non-sterile Federal Regulations

Safeway Update Automated Dispensing Update Prescription Drug Registry

Page 6: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

STATE ISSUES

American Society of Health System Pharmacists (ASHP) affiliation

Page 7: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

STATE LEGISLATIVE UPDATE

MPA 2013 Legislative Bill Tracking Update (page 6) HB 14 – Bonding Issue, included Missoula College

LC0119 HB 133 – BOP Housekeeping

Includes PBMs as practicing pharmacy and licenses them as mail order

HB 140 –Generally revising controlled substance laws Spice drugs and analogs

SB 84 – Establishes standards and structure for patient-centered medical home

LC1666 – Generally Revise Pharmacy Laws

Page 8: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

GOOD/BAD TIMING

Page 9: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

STATE LEGISLATIVE ISSUES

LC0545 (page 9 in blue packet) Revise collaborative practice laws for pharmacy

immunizations Eliminates need for collaborative agreements for CDC

recommended immunizations for patients age of 18 and older

Eliminated need for collaborative agreements for Influenza, Pneumonia, and TDaP for patients age 7 and older

Allows pharmacists to vaccinate patients age 7 and older for other immunizations with a prescription

Allows pharmacists to administer epinephrine and diphenhydramine

Page 10: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

STATE LEGISLATIVE ISSUES

LC0545 (page 20 of blue packet) Establish the pharmacy audit integrity act

Limit the burden of pharmacy audits Include private payors and Montana Medicaid, but not

Medicare Parts taken from several states (PA, UT, MN, etc.) Cannot recoup for typographical errors 10 day notice 200 claim/18 month window and not within first 5 days

of month Same auditing standards at all pharmacies May not require more stringent record keeping Pay for the audit with the recoupment

Page 11: C URRENT L AW AND PRACTICE I SSUES IN THE STATE AND N ATION Tony King, PharmD Corey Heffernan, PharmD Mark Meredith, PharmD Stuart Doggett, Executive Director,

QUESTIONS?